Crisis, Disaster and Risk Management, College of Natural Science, Sungkyunkwan University, Suwon, South Korea.
OMICS. 2022 Oct;26(10):567-579. doi: 10.1089/omi.2022.0064. Epub 2022 Sep 16.
The COVID-19 pandemic has underscored that systems medicine depends on health systems and services that can respond to planetary health threats in scale and with speed. After 2 years of the pandemic, there are lessons learned in South Korea, from governance to risk communication for planetary health. The learning is timely because COVID-19 likely signals future ecological crises and emerging pathogens amid the climate emergency in the 21st century. By the end of March 2022, South Korea, with a population of 51.6 million, administered more COVID-19 vaccine doses per 100 people than other developed countries, including United Kingdom, Italy, Australia, Israel, Germany, and United States. In South Korea, 233.47 doses of COVID-19 vaccine were administered per 100 people, while Italy (229.48), China (229.39), Australia (217.44), the United Kingdom (211.39), Israel (194.82), and the United States (170.59) fell behind in vaccine rollout. Korea's whole-of-government approach to robust COVID-19 vaccination rollout prompted broad interest in planetary health. Notwithstanding that vaccine rollout is a complex multifactorial outcome, six salient, and often interdependent, factors are identified in this study of South Korea: (1) governance system; (2) logistic capability; (3) delivery strategy and accessibility; (4) established public health infrastructure; (5) risk communication; and (6) public cooperation and engagement. Integration of these factors can create multisectoral synergy to achieve better outcomes in vaccine rollout. The lessons from South Korea can help cultivate planetary health action in other parts of the world during the current COVID-19 pandemic, and in ecological crises in the future.
COVID-19 大流行突显了系统医学依赖于能够大规模和快速应对行星健康威胁的卫生系统和服务。大流行两年后,韩国在治理到行星健康风险沟通方面都吸取了教训。由于 COVID-19 很可能是 21 世纪气候紧急情况下未来生态危机和新出现病原体的信号,因此这些经验教训是及时的。截至 2022 年 3 月底,韩国拥有 5160 万人口,每 100 人接种的 COVID-19 疫苗剂量超过其他发达国家,包括英国、意大利、澳大利亚、以色列、德国和美国。在韩国,每 100 人接种 COVID-19 疫苗 233.47 剂,而意大利(229.48)、中国(229.39)、澳大利亚(217.44)、英国(211.39)、以色列(194.82)和美国(170.59)的疫苗接种率较低。韩国政府采取整体方法大力推进 COVID-19 疫苗接种,引起了人们对行星健康的广泛关注。尽管疫苗接种是一个复杂的多因素结果,但在对韩国的研究中确定了六个突出且经常相互依存的因素:(1)治理系统;(2)后勤能力;(3)提供策略和可及性;(4)既定的公共卫生基础设施;(5)风险沟通;(6)公众合作和参与。这些因素的整合可以创造多部门协同效应,从而在疫苗接种方面取得更好的结果。韩国的经验教训可以帮助在当前 COVID-19 大流行期间以及在未来的生态危机中培养世界其他地区的行星健康行动。